Wound and skin infection treatment is of extreme importance as they are potent to complicate morbidity and cause anxiety which subsequently leads to patient discomfort and ultimately death. In order to treat a wound infection, a physician in common carries out advance wound treatment procedure using hydrogels, alginates, foam dressings, collagen and other wound care products. As advanced wound treatment provides effective and efficient solution by allowing fast healing of wounds, thus it is most commonly preferred over traditional treatment methods. Surgical wounds are further referred to as surgical site infection (SSI) by the US Centre for Disease Control and Prevention (CDC). About 77% of the deaths of surgical patients were related to surgical wound infection.
This report contains market size and forecasts of Wound and Skin Infection Treatment in Global, including the following market information:
Global Wound and Skin Infection Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Wound and Skin Infection Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Traditional Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Wound and Skin Infection Treatment include 3M, Coloplast, B. Braun Melsungen, Smith & Nephew, Genzyme, ConvaTec Healthcare, Human BioSciences, MediPurpose and Medtronic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Wound and Skin Infection Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Wound and Skin Infection Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Wound and Skin Infection Treatment Market Segment Percentages, by Type, 2021 (%)
Traditional Treatment
Basic Treatment
Bio-Active Treatment
Advanced Treatment
Global Wound and Skin Infection Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Wound and Skin Infection Treatment Market Segment Percentages, by Application, 2021 (%)
Biotechnology Companies
Pharmaceutical Companies
Hospital Laboratory and Diagnostic Laboratory
Academic and Research Institutes
Others
Global Wound and Skin Infection Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Wound and Skin Infection Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Wound and Skin Infection Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Wound and Skin Infection Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Coloplast
B. Braun Melsungen
Smith & Nephew
Genzyme
ConvaTec Healthcare
Human BioSciences
MediPurpose
Medtronic
J&J Medical
Acelity
Carinal Health
Medline
Integra LifeSciences
MiMedx Group
Mölnlycke